Circulating tumor cell detection and single‐cell analysis using an integrated workflow based on ChimeraX(®)‐i120 Platform: A prospective study

Circulating tumor cell (CTC) analysis holds great potential to be a noninvasive solution for clinical cancer management. A complete workflow that combined CTC detection and single‐cell molecular analysis is required. We developed the ChimeraX(®)‐i120 platform to facilitate negative enrichment, immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Peng‐Xiang, Sun, Yun‐Fan, Jin, Wei‐Xiang, Cheng, Jian‐Wen, Peng, Hai‐Xiang, Xu, Yang, Zhou, Kai‐Qian, Chen, Li‐Meng, Huang, Kai, Wu, Sui‐Yi, Hu, Bo, Zhang, Ze‐Fan, Guo, Wei, Cao, Ya, Zhou, Jian, Fan, Jia, Yang, Xin‐Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410565/
https://www.ncbi.nlm.nih.gov/pubmed/33301640
http://dx.doi.org/10.1002/1878-0261.12876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410565/
https://www.ncbi.nlm.nih.gov/pubmed/33301640
http://dx.doi.org/10.1002/1878-0261.12876

Ejemplares similares